Diagnostic Microbiology and Infectious Disease

Article	Citations
Evaluation of a commercially-available surrogate virus neutralization test for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)	81
The use of copper to help prevent transmission of SARS-coronavirus and influenza viruses. A general review	78
Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection	60
Seroprevalence of SARS-CoV-2 (COVID-19) among healthcare workers in Saudi Arabia: comparing case and control hospitals	54
Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays	51
Evaluation of the Cue Health point-of-care COVID-19 (SARS-CoV-2 nucleic acid amplification) test at a community drive through collection center	46
Evaluation of the BioFire® COVID-19 test and Respiratory Panel 2.1 for rapid identification of SARS-CoV-2 in nasopharyngeal swab samples	45
COVID-19 in Brazil: 150,000 deaths and the Brazilian underreporting	41
Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection	38
Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type	36
Comparison of SARS-CoV-2 IgM and IgG seroconversion profiles among hospitalized patients in two US cities	34
The potential of volatile organic compounds-based breath analysis for COVID-19 screening: a systematic review & meta-analysis.	34
Pooled Testing Strategies for SARS-CoV-2 diagnosis: A comprehensive review	32
Performance of a multiplex polymerase chain reaction panel for identifying bacterial pathogens causing pneumonia in critically ill patients with COVID-19	32
Duration of SARS-CoV-2 viremia and its correlation to mortality and inflammatory parameters in patients hospitalized for COVID-19: a cohort study	31
Activity of aztreonam in combination with ceftazidime–avibactam against serine- and metallo-β-lactamase–producing Pseudomonas aeruginosa	30
Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies	28
Enhanced Detection of Community-Acquired Pneumonia Pathogens With the BioFire® Pneumonia FilmArray® Panel	28
Advances in rapid diagnostics for bloodstream infections	28
Evaluation of a novel chromogenic medium for Candida spp. identification and comparison with CHROMagar™ Candida for the detection of Candida auris in surveillance samples	28
Laboratory evaluation of the BioFire FilmArray Pneumonia plus panel compared to conventional methods for the identification of bacteria in lower respiratory tract specimens: a prospective cross-sectio	28
Changes in healthcare managing COVID and non–COVID-19 patients during the pandemic: striking the balance	27
Detection of SARS-CoV-2 IgG antibodies in dried blood spots	27
A multiplex polymerase chain reaction assay for antibiotic stewardship in suspected pneumonia	25
Time to positivity of acute and chronic periprosthetic joint infection cultures	25

Commercial Interferon-gamma release assay to assess the immune response to first and second doses of mRNA vaccine in previously COVID-19 infected versus uninfected individuals	24
SARS-CoV-2 infection and COVID-19 severity in individuals with prior seasonal coronavirus infection	24
Antimicrobial susceptibility of Gram-negative bacteria from intensive care unit and non-intensive care unit patients from United States hospitals (2018–2020)	24
In vitro activity of Ceftazidime–Avibactam and its comparators against Carbapenem resistant Enterobacterales collected across India: results from ATLAS surveillance 2018 to 2019	24
The importance of cycle threshold values in interpreting molecular tests for SARS-CoV-2	23
Surgical site infection after liver transplantation in the era of multidrug-resistant bacteria: what new risks should be considered?	22
Prospective clinical validation of 3D printed nasopharyngeal swabs for diagnosis of COVID-19	21
Frequency of respiratory pathogens other than SARS-CoV-2 detected during COVID-19 testing	21
Identification of bacterial co-detections in COVID-19 critically Ill patients by BioFire® FilmArray® pneumonia panel: a systematic review and meta-analysis	21
Trends of major antimicrobial resistance phenotypes in enterobacterales and gram-negative non-fermenters from ATLAS and EARS-net surveillance systems: Italian vs. European and global data, 2008-2018	21
Bacterial co-infections in COVID-19 pneumonia in a tertiary care hospital: Surfing the first wave	20
Two serological approaches for detection of antibodies to SARS-CoV-2 in different scenarios: a screening tool and a point-of-care test	20
Targeted next generation sequencing for elbow periprosthetic joint infection diagnosis	19
SARS-CoV-2 IgG antibody responses in New York City	19
Diagnostic pre-screening method based on N-gene dropout or delay to increase feasibility of SARS-CoV-2 VOC B.1.1.7 detection	18
SARS-CoV-2 N gene mutations impact detection by clinical molecular diagnostics: reports in two cities in the United States	18
Risk factors and outcomes of bloodstream infections caused by Acinetobacter baumannii: a case–control study	18
A brief history of OspA vaccines including their impact on diagnostic testing for Lyme disease	18
Comparing mortality in patients with carbapenemase-producing carbapenem resistant Enterobacterales and non-carbapenemase-producing carbapenem resistant Enterobacterales bacteremia	18
A comprehensive and contemporary “snapshot” of β-lactamases in carbapenem resistant Acinetobacter baumannii	17
Assessment of sample pooling for SARS-CoV-2 molecular testing for screening of asymptomatic persons in Tunisia	17
Respiratory bacterial pathogen spectrum among COVID-19 infected and non–COVID-19 virus infected pneumonia patients	17
Multiplex RT-PCR provides improved diagnosis of skin and nail dermatophyte infections compared to microscopy and culture: a laboratory study and review of the literature	16
Systematic analysis, identification, and use of CRISPR/Cas13a–associated crRNAs for sensitive and specific detection of the lcrV gene of Yersinia pestis	16
Dynamic of humoral response to SARS-CoV-2 anti-Nucleocapsid and Spike proteins after CoronaVac vaccination	16
Comparing probability of target attainment against Staphylococcus aureus for ceftaroline fosamil, vancomycin, daptomycin, linezolid, and ceftriaxone in complicated skin and soft tissue infection using	16
Invasive pulmonary aspergillosis after treatment with tocilizumab in a patient with COVID-19 ARDS: a case report	16
Evaluation of Three Immunoassays for the Rapid Detection of SARS-CoV-2 antigens	16
Balamuthia mandrillaris encephalitis in a child: case report and literature review	16
Understanding false positives and the detection of SARS-CoV-2 using the Cepheid Xpert Xpress SARS-CoV-2 and BD MAX SARS-CoV-2 assays	15
Carbapenemase -producing Pseudomonas aeruginosa isolates from Turkey: first report of P. aeruginosa high-risk clones with VIM-5– and IMP-7–type carbapenemases in a tertiary hospital	15
Evaluation and comparison of automated and manual ELISA for diagnosis of chronic pulmonary aspergillosis (CPA) in Indonesia	14
Performance of a rapid antigen test for SARS-CoV-2 in Kenya	14
Evaluation of diagnostic accuracy of loop-mediated isothermal amplification method (LAMP) compared with polymerase chain reaction (PCR) for Leptospira spp. in clinical samples: a systematic review and	14
Caution in interpretation of SARS-CoV-2 quantification based on RT-PCR cycle threshold value	14
A deletion in the N gene of SARS-CoV-2 may reduce test sensitivity for detection of SARS-CoV-2	14
Ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam activities against multidrug-resistant Enterobacterales from United States Medical Centers (2018–2022)	14
A systematic review and meta-analysis of Listeria monocytogenes isolated from human and non-human sources: the antibiotic susceptibility aspect	14
Point-of-care tests for malaria: speeding up the diagnostics at the bedside and challenges in malaria cases detection	14
Differential diagnosis and prospective grading of COVID-19 at the early stage with simple hematological and biochemical variables	14
Comparison of abbott ID NOW COVID-19 rapid molecular assay to cepheid xpert xpress SARS-CoV-2 assay in dry nasal swabs	14
Evaluation of the Abbott PanbioTM COVID-19 Ag rapid antigen test for the detection of SARS-CoV-2 in asymptomatic Canadians	14
Biomarkers for the diagnosis of invasive candidiasis in immunocompetent and immunocompromised patients	14
Molecular epidemiology of NDM-5-producing Escherichia coli high-risk clones identified in two Italian hospitals in 2017-2019	13
Plasma cell-free metagenomic next generation sequencing in the clinical setting for the diagnosis of infectious diseases: a systematic review and meta-analysis	13
Evaluation of a SARS-CoV-2 lateral flow assay using the plaque reduction neutralization test	13
The reliability of saliva for the detection of SARS-CoV-2 in symptomatic and asymptomatic patients: Insights on the diagnostic performance and utility for COVID-19 screening	13
Retrospective clinical evaluation of 4 lateral flow assays for the detection of SARS-CoV-2 IgG	13
Clindamycin combination treatment for the treatment of bone and joint infections caused by clindamycin-susceptible, erythromycin-resistant Staphylococcus spp.	13
Microbiological diagnosis of Acanthamoebic keratitis: experience from tertiary care center of North India	13

Comparison of reverse-transcription qPCR and droplet digital PCR for the detection of SARS-CoV-2 in clinical specimens of hospitalized patients	13
SARS-CoV-2 antibody profile of naturally infected and vaccinated individuals detected using qualitative, semi-quantitative and multiplex immunoassays	13
Impact of the FilmArray meningitis/encephalitis panel on antimicrobial duration among patients with suspected central nervous system infection	13
In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years	12
Diagnostic value of galactomannan in serum and bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in non-neutropenic patients	12
Respiratory co-infections with COVID-19 in the Veterans Health Administration, 2020	12
Verification of the Abbott Alinity m Resp-4-Plex assay for detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus	12
Evaluation of commercial SARS-CoV-2 serological assays in Canadian public health laboratories	12
Comparison of SARS-CoV-2 molecular detection in nasopharyngeal swab, saliva, and gargle samples	12
Analytical performance of the Xpert MTB/XDR® assay for tuberculosis and expanded resistance detection	12
Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in a clinical practice setting of China	12
Procalcitonin as a biomarker for ventilator associated pneumonia in COVID-19 patients: Is it an useful stewardship tool?	12
In vitro activity of cefepime/zidebactam (WCK 5222) against recent Gram-negative isolates collected from high resistance settings of Greek hospitals	12
Evaluation of four laboratory-based SARS-CoV-2 IgG antibody immunoassays	11
Negative impact of the COVID-19 pandemic on the timely diagnosis of tick-borne infections	11
Elderly versus nonelderly patients with invasive fungal infections: species distribution and antifungal resistance, SENTRY antifungal surveillance program 2017-2019	11
Sample pooling on the Cepheid Xpert® Xpress SARS-CoV-2 assay	11
Accelerating the global response against the exponentially growing COVID-19 outbreak through decent data sharing	11
The Biofire® Filmarray® Pneumonia Plus panel for management of lower respiratory tract infection in mechanically-ventilated patients in the COVID-19 era: a diagnostic and cost-benefit evaluation	11
Assay dependence of long-term kinetics of SARS-CoV-2 antibodies	11
Algorithm for rational use of Film Array Pneumonia Panel in bacterial coinfections of critically ill ventilated COVID-19 patients	10
Predictors of respiratory bacterial co-infection in hospitalized COVID-19 patients	10
Testing individual and pooled saliva samples for sars-cov-2 nucleic acid: a prospective study	10
Sensitivity and specificity of multibacillary and paucibacillary leprosy laboratory tests: A systematic review and meta-analysis	10
In vitro susceptibility patterns for rapidly growing nontuberculous mycobacteria in the United States	10
Update on the in vitro activity of dalbavancin against indicated species (Staphylococcus aureus, Enterococcus faecalis, β-hemolytic streptococci, and Streptococcus anginosus group) collected from Unit	10
Performance of rapid diagnostic tests for hepatitis B surface antigen detection in serum or plasma	10
Comparison of 2 fully automated tests detecting antibodies against nucleocapsid N and spike S1/S2 proteins in COVID-19	10
Predictive ability of LRINEC score in the prediction of limb loss and mortality in diabetic foot infection	10
Development and validation of a new scoring system for the early diagnosis of tuberculous meningitis in adults	10
Abbott ID now COVID-19 assay performance: a year in review	10
Evaluation of the Boson rapid Ag test vs RT–PCR for use as a self–testing platform	10
Staphylococcus pettenkoferi-positive Blood cultures in Hospitalized Patients in a Multi-site Tertiary Center	10
Evaluation of observed and unobserved self-collection of saline gargle samples for the detection of SARS-CoV-2 in outpatients	10
Diagnostic accuracy of rapid antigen test for COVID-19 in an emergency department	9
In vitro activity of imipenem-relebactam against various resistance phenotypes/genotypes of Enterobacterales and Pseudomonas aeruginosa isolated from patients across Canada as part of the CANWARD stud	9
In vitro activity of ceftazidime-avibactam and comparators against Enterobacterales and Pseudomonas aeruginosa isolates from Central Europe and Israel, 2014–2017 and 2018	9
Seroprevalence of SARS-CoV-2 infection in health care workers of a teaching hospital in Belgium: self-reported occupational and household risk factors for seropositivity	9
Elucidating the role of procalcitonin as a biomarker in hospitalized COVID-19 patients	9
A deletion in the N gene may cause diagnostic escape in SARS-CoV-2 samples	9
Activity of imipenem-relebactam and ceftolozane-tazobactam against carbapenem-resistant Pseudomonas aeruginosa and KPC-producing Enterobacterales	9
SARS-CoV-2 reinfection in a healthcare professional in inner Sao Paulo during the first wave of COVID-19 in Brazil	9
False-positive SARS-CoV-2 serology in 3 children with Kawasaki disease	9
Kinetics of anti-SARS-CoV-2 IgG antibody levels and potential influential factors in subjects with COVID-19: A 11-month follow-up study	9
In vitro antibacterial activity of cefiderocol against recent multidrug-resistant carbapenem-nonsusceptible Enterobacterales isolates	9
Clinical evaluation of the antibody response in patients with COVID-19 using automated high-throughput immunoassays	9
Susceptibility trends of ceftolozane/tazobactam and comparators when tested against U.S. gram-negative bacterial surveillance isolates (2012–2018)	9
Clinical outcomes of combination versus monotherapy for gram negative non-HACEK infective endocarditis	9
A systematic review and meta-analysis of studies on the diagnostic accuracy and screening of tests to detect antimicrobial resistance in leprosy	9
Incidence and utility of follow-up blood cultures in cancer patients with gram-negative bacteremia	9
A quantitative enzyme-linked immunoassay (ELISA) to approximate complement-fixing antibody titers in serum from patients with coccidioidomycosis	9
Aztreonam in combination with imipenem-relebactam against clinical and isogenic strains of serine and metallo-β-lactamase-producing enterobacterales	9
In vitro activity of ceftaroline and ceftobiprole against clinical isolates of Gram-positive bacteria from infective endocarditis: are these drugs potential options for the initial management of this	9
Evaluation of the rapid antigen detection test STANDARD F COVID-19 Ag FIA for diagnosing SARS-CoV-2: experience from an Emergency Department	8
Emergence and onward transmission of a SARS-CoV-2 E484K variant among household contacts of a bamlanivimab-treated patient	8
Clinical impact of implementation of rapid diagnostic testing of blood cultures with Staphylococcus aureus on patient outcomes	8
Two SARS-CoV-2 IgG immunoassays comparison and time-course profile of antibodies response	8
Evaluation of independent self-collected blood specimens for COVID-19 antibody detection among the US veteran population	8
High level of colonization with third-generation cephalosporin-resistant Enterobacterales in African community settings, Ghana	8
In vitro activity of ceftolozane-tazobactam and ceftazidime-avibactam against Pseudomonas aeruginosa isolated from patients with cystic fibrosis	8
Clinical evaluation of nasopharyngeal, midturbinate nasal and oropharyngeal swabs for the detection of SARS-CoV-2	8
Presumptive positive with the Cepheid Xpert Xpress SARS-CoV-2 assay due to N mutations in the Delta variant	8
The diagnostic and clinical utility of microbial cell-free DNA sequencing in a real-world setting	8
Validation of SARS CoV-2 detection by real-time PCR in matched pooled and deconvoluted clinical samples before and after nucleic acid extraction: a study in tertiary care hospital of North India	8
Comparison of mortality, stroke, and relapse for methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infective endocarditis: a retrospective cohort study	8
Evaluation of the molecular detection of ciprofloxacin resistance in Neisseria gonorrhoeae by the ResistancePlus GC assay (SpeeDx)	8
Performance of Xpert MTB/RIF Ultra assay on respiratory and extra-respiratory samples in a high-resource setting with a low tuberculosis prevalence	8
Development of a recombinase polymerase amplification assay for rapid detection of Streptococcus suis type 2 in nasopharyngeal swab samples	8
Microbiota and parasite relationship	8
Heterologous booster COVID-19 vaccination elicited potent immune responses in HCWs	8
Coinfections among hospitalized patients with covid-19 in the first pandemic wave	7
The challenge of COVID-19 for a Clinical Microbiology Department	7
Invasive pneumococcal disease caused by serotypes 22F and 33F in Canada: the SAVE study 2011–2018	7
Pooling samples: a testing option for SARS-CoV-2 during a supply shortage	7
In vitro activity of new tetracycline analogues omadacycline and eravacycline against clinical isolates of Helicobacter pylori collected in China	7
COVID-19 in Brazil: a 3-year update	7
Distribution of genes encoding 16S rRNA methyltransferase in plazomicin-nonsusceptible carbapenemase-producing Enterobacterales in Brazil	7
Characterization of abscesses from liver, pancreas and kidney using deep sequencing of the 16S rRNA gene	7
Increased rates of extended-spectrum beta-lactamase isolates in patients hospitalized with culture-positive urinary Enterobacterales in the United States: 2011 – 2020	7
Comparison of PCV-10 and PCV-13 vaccine coverage for invasive pneumococcal isolates obtained across Canadian geographic regions, SAVE 2011 to 2017	7

Comparison of diagnostic performance of five molecular assays for detection of SARS-CoV-2	7
Test, trace, isolate: evidence for declining SARS-CoV-2 PCR sensitivity in a clinical cohort	7
IgG anti-spike antibody levels in healthcare workers with and without prior COVID-19 up to 3 months after BNT162b2 vaccination	7
Performance of PhenoMatrix for the detection of Group B Streptococcus from recto-vaginal swabs	7
Evaluation of five widely used serologic assays for antibodies to SARS-CoV-2	7
Evaluation of selected variables to determine if any had predictive value for, or correlated with, residual symptoms at approximately 12 months after diagnosis and treatment of early Lyme disease	7
Dissemination of NDM-producing bacteria in Southern Brazil	7
Follow-up testing of borderline SARS-CoV-2 patients by rRT-PCR allows early diagnosis of COVID-19	7
Temocillin susceptibility among Enterobacterales strains recovered from blood culture in France	7
Analysis of sputum/tracheal aspirate and nasopharyngeal samples for SARS-CoV-2 detection by laboratory-developed test and Panther Fusion system	7
Emergence of GES-19-producing Pseudomonas aeruginosa exoU+ belonging to the global high-risk clone ST235 in cystic fibrosis infection	7
Evaluation of automated antigen detection test for detection of SARS-CoV-2	7
Antibacterial activity of gallium nitrate against polymyxin-resistant Klebsiella pneumoniae strains	7
Detection of potential enteric pathogens in children with severe acute gastroenteritis using the filmarray: Results from a three - years hospital-based survey in Northern Italy	7
Validity of at-home rapid antigen lateral flow assay and artificial intelligence read to detect SARS-CoV-2	7
Development and comparative evaluation of SARS-CoV-2 S-RBD and N based ELISA tests in various African endemic settings	6
Rapid and sensitive detection of SARS-CoV-2 variants in nasopharyngeal swabs and wastewaters	6
Anti-staphylococcal lysin, LSVT-1701, activity: In vitro susceptibility of Staphylococcus aureus and coagulase-negative staphylococci (CoNS) clinical isolates from around the world collected from 2002	6
Frequency of natural antibodies and concordance analysis for anti-TOXOPLASMA IgM tests in Colombian sera of pregnant women	6
Concern levels of beta-lactamase-producing Gram-negative bacilli in hospital wastewater: hotspot of antimicrobial resistance in Latin-America	6
Extractionless nucleic acid detection: a high capacity solution to COVID-19 testing	6
Rapid detection of carbapenemase-producing Pseudomonas spp. using the NitroSpeed-Carba NP test	6
Analytical and clinical evaluation of new automated chemiluminescent immunoassays for the detection of IgG and IgM anti-Bartonella henselae antibodies	6
Development of a species-specific real-time PCR test for Chlamydia psittaci and its employment in the investigation of zoonotic transmission from racing pigeons in Denmark	6
Analytical performance and potential clinical utility of the GenMark Dx ePlex® blood culture identification gram-positive panel	6
Enterococcus faecalis in blood cultures—a prospective study on the role of persistent bacteremia	6
Mobile genetic elements responsible for discordant Staphylococcus aureus phenotypes and genotypes in the same blood culture bottle	6
Distribution of virulence genes and capsule types in Klebsiella pneumoniae among bloodstream isolates from patients with hematological malignancies	6
Value analysis of next-generation sequencing combined with Xpert in early precise diagnosis of pulmonary tuberculosis	6
Impact of RNA degradation on influenza diagnosis in the surveillance system	6
Clinical evaluation of dithiothreitol in comparison with sonication for biofilm dislodgement in the microbiological diagnosis of periprosthetic joint infection	6
SARS-CoV-2 diagnostics: Some reflections on current assays	6
Rare Lelliottia nimipressuralis from a wound infection case report using whole genome sequencing-based bacterial identification	6
Fast and reliable detection of carbapenemase genes in various Gram negatives using a new commercially available fluorescence-based real-time polymerase chain reaction platform	6
Epidemiology and regional variation of nonsusceptible and multidrug-resistant Pseudomonas aeruginosa isolates from intensive versus non-intensive care units across multiple centers in the United State	6
A real-time multiplex PCR assay for detection of the causative agents of rat bite fever, Streptobacillus moniliformis and zoonoticStreptobacillus species	6
Rapid detection of cagA-positive Helicobacter pylori based on duplex recombinase aided amplification combined with lateral flow dipstick assay	6
Efficient automated semi-quantitative urine culture analysis via BD Urine Culture App	6
Evaluation of T cell responses with the QuantiFERON SARS-CoV-2 assay in individuals with 3 doses of BNT162b2 vaccine, SARS-CoV-2 infection, or hybrid immunity	6
Antibiotic susceptibility testing of Staphylococcus aureus using the Biolog OmniLog® system, a metabolic phenotyping assay	6
Emerging resistance to beta-lactams in Pantoea ananatis isolated from an immunocompetent patient with bacteremia	6
Molecular detection of Mycobacterium tuberculosis in blood stained sputum samples using GeneXpert PCR assay	6
Assessment of invitrosynergy of daptomycin or vancomycin plus ceftaroline for daptomycin non-susceptible Staphylococcus aureus	6
Performance of ceftriaxone susceptibility testing on the Accelerate Pheno® system of ESBL-producing isolates	6
Dynamics of nosocomial parainfluenza virus type 3 and influenza virus infections at a large German University Hospital between 2012 and 2019	6
Evaluation of the Cepheid Xpert SA Nasal Complete for direct detection of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in nasal swabs from pediatric patients	6
Increase in amoxicillin resistance in Helicobacter pylori from Bulgarian patients over 15 years	6
Evaluation of novel immunological rapid test (K.N.I.V.O. Detection K-Set) for rapid detection of carbapenemase producers in multidrug-resistant gram negatives	5
COVID-19: Is there a role for Western blots and skin testing for determining immunity and development of a vaccine?	5
An Australian diagnostic microbiology surge response to the COVID-19 pandemic	5
Target capture sequencing of SARS-CoV-2 genomes using the ONETest Coronaviruses Plus	5
Culture-independent multilocus sequence typing of Pseudomonas aeruginosa for cross-infection screening	5
microRNA as biomarkers in tuberculosis: a new emerging molecular diagnostic solution	5
Do written diagnosis-treatment recommendations on microbiological test reports improve the management of Staphylococcus aureus bacteremia? A single-center, retrospective, observational study	5
Identification of pathogens from the upper respiratory tract of adult emergency department patients at high risk for influenza complications in a pre-Sars-CoV-2 environment	5
Optimizing outcomes using vancomycin therapeutic drug monitoring in patients with MRSA bacteremia: trough concentrations or area under the curve?	5
Activity of cefiderocol, ceftazidime-avibactam, and eravacycline against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012–20017) in relation to phylogenetic backgroun	5
Emerging multidrug resistance contributes to treatment failure in Mycoplasma genitalium infected patients in China	5
CagE, cagA and cagA 3′ region polymorphism of Helicobacter pylori and their association with the intra-gastric diseases in Moroccan population	5
Clinical performance and analytical accuracy of a C6 peptide-based point-of-care lateral flow immunoassay in Lyme borreliosis serology	5
Identification of Streptococcus dysgalactiae using matrix-assisted laser desorption/ionization-time of flight mass spectrometry; refining the database for improved identification	5
Aggregation of data from 4 clinical studies demonstrating efficacy of single-dose doxycycline postexposure for prevention of the spirochetal infections: Lyme disease, syphilis, and tick-borne relapsin	5
The clinical significance of staphylococcus pettenkoferi: a retrospective review at a tertiary care medical center	5
SARS-CoV-2 screening in patients in need of urgent inpatient treatment in the Emergency Department (ED) by digitally integrated point-of-care PCR: a clinical cohort study	5
SARS-CoV-2 variant detection with ADSSpike	5
Whole-genome analysis of SARS-CoV-2 samples indicate no tissue specific genetic adaptation of the virus in COVID-19 patients’ upper and lower respiratory tract	5
Direct antimicrobial susceptibility testing (AST) from positive blood cultures using Microscan system for early detection of bacterial resistance phenotypes	5
Evaluation of the Roche-SD Biosensor rapid antigen test: Antigen is not reliable in detecting SARS-CoV-2 at the early stage of infection with respiratory symptoms	5
Activity of imipenem/relebactam and comparators against gram-negative pathogens from patients with bloodstream infections in the United States and Canada – SMART 2018-2019	5
Probability of target attainment of oral antimicrobials for Escherichia coli and Klebsiella pneumoniae based on Monte Carlo simulations	5
Point-of-care molecular diagnostics for the detection of group A Streptococcus in non-invasive skin and soft tissue infections: a validation study	5
Comparative genomics of Enterobacter cloacae complex before and after acquired clinical resistance to Ceftazidime-Avibactam	5
Comparison of the Bruker Microflex LT and Zybio EXS2600 MALDI TOF MS systems for the identification of clinical microorganisms	4
Values of combined C-reactive protein, procalcitonin and serum amyloid A in differential diagnosis of bacterial and non-bacterial community acquired pneumonia in children	4
Stability of MERS-CoV RNA on spin columns of RNA extraction kit at room temperature	4
Analytical evaluation of the cobas® 6800 system for the detection and quantification of BK Virus (BKV) and Epstein Barr Virus (EBV) at a US solid organ and hematopoietic stem cell transplant center	4
Impact of a pharmacist-facilitated, evidence-based bundle initiative on Staphylococcus aureus bacteremia management	4
Characteristics and predictors of treatment failure with intravenous tigecycline monotherapy among adult patients with severe Clostridioides (Clostridium) difficile infection: a single-centre observat	4
Rate and consequences of missed Clostridioides (Clostridium) difficile infection diagnosis from nonreporting of Clostridioides difficile results of the multiplex GI PCR panel: experience from two-hosp	4
Be aware of Shiga-toxin 2f-producing Escherichia coli: case report and false-negative results with certain rapid molecular panels	4
Correlation of MRSA polymerase chain reaction (PCR) wound swab testing and wound cultures in skin and soft tissue infections	4
False positive Herpes Simplex IgM serology in COVID-19 patients correlates with SARS-CoV-2 IgM/IgG seropositivity	4
Serological response in health care workers after a single dose of SARS-CoV-2 vaccine using six automated SARS-CoV-2 antibody assays	4
The use of BCYE medium for the detection of Legionella in environmental water samples: an appropriate update to ISO 11731:2017 standard?	4
Implementation of the Abbott ID Now COVID-19 assay at a tertiary care center: a prospective pragmatic implementation study during the third wave of SARS-CoV-2 in Ontario	4
Real-time PCR assays to detect 10 Shiga toxin subtype (Stx1a, Stx1c, Stx1d, Stx2a, Stx2b, Stx2c, Stx2d, Stx2e, Stx2f, and Stx2g) genes	4
Diagnostic performance of Ion 16S metagenomics kit and Ion reporter metagenomics workflow for bacterial pathogen detection in culture-negative clinical specimens from sterile sources	4
The utility of the syphilis enzyme immunoassay IgM in the diagnosis of congenital syphilis	4
Microbiological investigation of samples collected from healthy middle ears during cochlear implant surgery	4
Comparison of BD MAX Check-Points CPO assay with Cepheid Xpert Carba-R assay for the detection of carbapenemase-producing Enterobacteriaceae directly from rectal swabs	4
An inventory of 44 qPCR assays using hydrolysis probes operating with a unique amplification condition for the detection and quantification of antibiotic resistance genes	4
Diagnostic value of bronchoalveolar lavage fluid cryptococcal antigen-lateral flow immunochromatographic assay for pulmonary cryptococcosis in non-HIV patients	4
Impact of COVID-19 pandemic on blood culture practices and bacteremia epidemiology	4
Evaluation of the selection of cerebrospinal fluid testing in suspected meningitis and encephalitis	4
Application of digital PCR to determine the reliability of Xpert Xpress SARS-CoV-2 assay with envelope (E) gene negative and nucleocapsid (N2) gene positive results	4